Innovative Trial Design
OSE Immunotherapeutics and One2Treat jointly won the Innovation award for Endpoint Design in the 2025 Clinical Trials Arena Excellence Awards
READ MORE →
Trial Designs
OSE Immunotherapeutics: One2Treat Voice for outcomes prioritization in ARTEMIA
READ MORE →
Innovative Trial Design
Benefit-risk analyses in cancer treatment
READ MORE →
Innovative Trial Design
Design a patient-centric trial & avoid a demonstration of “non-inferiority”
READ MORE →
Innovative Trial Design
Using more information for fewer patients.
READ MORE →